Abbott Laboratories's change in receivables for the quarter that ended in Dec. 2023 was $68 Mil. It means Abbott Laboratories's Accounts Receivable
declined by $68 Mil
from Sep. 2023 to Dec. 2023 .
Abbott Laboratories's change in receivables for the fiscal year that ended in Dec. 2023 was $-356 Mil. It means Abbott Laboratories's Accounts Receivable
increased by $356 Mil
from Dec. 2022 to Dec. 2023 .
Abbott Laboratories's Accounts Receivable for the quarter that ended in Dec. 2023 was $6,565 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Abbott Laboratories's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 58.50.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Abbott Laboratories's liquidation value for the
three
months ended in Dec. 2023 was $-18,899 Mil.
Abbott Laboratories Change In Receivables Historical Data
The historical data trend for Abbott Laboratories's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-356 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (NYSE:ABT) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Abbott Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories Change In Receivables Related Terms
Thank you for viewing the detailed overview of Abbott Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Abbott Laboratories (Abbott Laboratories) Business Description
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABT has been successfully added to your 